Raymond Liang
University of Hong Kong
251 Papers
2.9K Citations
Raymond Liang is an academic researcher from University of Hong Kong. The author has contributed to research in topics: Lymphoma & Transplantation. The author has an hindex of 53, co-authored 245 publications. Previous affiliations of Raymond Liang include University of Malaya & Queen Mary University of London.
Chat about Author
Papers
Stage-Specific Manifestation of Mold Infections in Bone Marrow Transplant Recipients: Risk Factors and Clinical Significance of Positive Concentrated Smears
Kwok-Yung Yuen,Patrick C. Y. Woo,Mary S.M. Ip,Raymond Liang,Edmund K. W. Chiu,Hong Siau,Pak-Leung Ho,FE Chen,Tai-Kwong Chan +8 more
TL;DR: A stage-specific manifestation of mold infection was observed: 67% of mold infections occurred during acute graft-vs-host disease (GVHD) a median of 47 days after transplantation, whereas 9% of Mold infections occurred as rapidly fatal invasive disease before engraftment.
Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients.
TL;DR: The in vitro susceptibilities and the clinical responses suggested that, with the possible exception of Pseudomonas spp.
83
Methylation of p15 and p16 genes in adult acute leukemia: lack of prognostic significance.
TL;DR: The frequency and prognostic significance of p15 and p16 gene methylation in adult acute leukemia is investigated and gene‐promoter methylation is investigated for its role in transcription inactivation.
75
Autologous bone marrow transplantation for primary nasal T/NK cell lymphoma
TL;DR: In this article, high-dose cyclophosphamide, BCNU and etoposide were used for conditioning and three patients with relapsed primary nasal T/NK cell lymphoma were treated with autologous bone marrow rescue at Queen Mary Hospital, Hong Kong.
74
Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation.
TL;DR: Use of famciclovir significantly reduced hepatitis due to hepatitis B virus reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation.
71